Vigimed System is the only channel for notifying adverse events of manipulated medications, including GLP-1 agonists

News Healthcare & Pharma Guidance

Date: 27th Aug, 2025 Source: National Health Surveillance Agency (Anvisa) Country: Brazil Original Source

Brief

On 27/08/2025, the National Health Surveillance Agency (Anvisa) issued an update regarding Vigimed System is the only channel for notifying adverse events of manipulated medications, including GLP-1 agonists. This system provides a global data collection platform, allowing for concrete information generation to inform decision-making in public health surveillance.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Vigimed System is the only channel for notifying adverse events of manipulated medications, including GLP-1 agonists

Brief

National Health Surveillance Agency (Anvisa)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Vigimed System is the only channel for notifying adverse events of manipulated medications, including GLP-1 agonists

Brief

National Health Surveillance Agency (Anvisa)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.